Table of Content

1 Market
1.1 Product Definition
1.1.1 Inclusion and Exclusion Criteria
1.2 Market Scope
1.2.1 Scope of the Study
1.2.2 Key Questions Answered in the Report
1.3 Research Methodology
1.3.1 Nucleic Acid Sample Preparation Market: Research Methodology
1.3.2 Data Sources
1.3.2.1 Primary Data Sources
1.3.2.2 Secondary Data Sources
1.3.3 Market Estimation Model
1.3.4 Criteria for Company Profiling
1.4 Market Overview
1.4.1 Market Definition
1.4.2 Market Footprint and Growth Potential, $Million, 2021-2032
1.5 Addressable Market Size and Growth Potential ($Million), 2021-2032
1.5.1 Europe
1.6 Industry Participants Landscape

2 Nucleic Acid Sample Preparation Market, Industry Analysis
2.1 Industry Insights
2.1.1 Legal Requirements and Framework in Europe
2.2 Patent Analysis
2.2.1 Patent Filing Trend
2.2.2 Patent Analysis (by Year)
2.2.3 Patent Analysis (by Country)
2.2.4 Patent Analysis (by Region)
2.3 Impact of COVID-19 on the Nucleic Acid Sample Preparation Market

3 Nucleic Acid Sample Preparation Market: Market Dynamics
3.1 Overview
3.2 Market Drivers
3.2.1 Increasing Use of Nucleic Acid Molecules in Various Therapeutic Areas
3.2.2 Advancement in the Nucleic Acid Extraction/Isolation Techniques
3.2.3 Advantages of Automated Sample Preparation Workstations
3.2.4 Increasing Demand for Downstream Applications such as Next-Generation Sequencing (NGS)
3.3 Market Restraints
3.3.1 High Cost of Automated Workstations
3.3.2 Rigid Regulatory Standards
3.4 Market Opportunities
3.4.1 Technological Advancements in Automated Sample Preparation Workstations
3.4.2 Nucleic Acid Molecules for Biobanking in Healthcare
3.4.3 Growth in Emerging Nations

4 Competitive Landscape
4.1 Overview
4.2 Corporate Strategies
4.2.1 Mergers and Acquisitions
4.2.2 Synergistic Activities
4.2.3 Business Expansions
4.3 Business Strategies
4.3.1 Product Launches
4.4 Market Share Analysis

5 Nucleic Acid Sample Preparation Market, by Region ($Million), 2021-2032
5.1 Overview
5.2 Europe
5.2.1 Germany
5.2.2 France
5.2.3 U.K.
5.2.4 Italy
5.2.5 Spain
5.2.6 Rest-of-Europe

6 Company Profiles
6.1 Overview
6.2 Endress+Hauser Group Services AG (Analytik Jena GmbH)
6.2.1 Company Overview
6.2.2 Role of Endress+Hauser Group Services AG (Analytik Jena GmbH) in the Global Nucleic Acid Sample Preparation Market
6.2.3 Key Customers of the Company
6.2.4 Key Competitors of the Company
6.2.5 Business Strategies
6.2.6 Financials
6.2.7 Endress+Hauser Group Services AG (Analytik Jena GmbH): Revenue (by Region), $Million, 2019-2021
6.2.8 Key Insights about the Financial Health of the Company
6.2.9 Analyst Perspective
6.3 Eppendorf SE
6.3.1 Company Overview
6.3.2 Role of Eppendorf SE in the Nucleic Acid Sample Preparation Market
6.3.3 Key Competitors of the Company
6.3.4 Financials
6.3.5 Key Insights about the Financial Health of the Company
6.3.6 Analyst Perspective
6.4 F. Hoffmann-La Roche Ltd
6.4.1 Company Overview
6.4.2 Role of F. Hoffmann-La Roche Ltd in the Nucleic Acid Sample Preparation Market
6.4.3 Key Competitors of the Company
6.4.4 Business Strategies
6.4.5 Financials
6.4.6 Key Insights about the Financial Health of the Company
6.4.7 Analyst Perspective
6.5 Merck KGaA
6.5.1 Company Overview
6.5.2 Role of Merck KGaA in the Nucleic Acid Sample Preparation Market
6.5.3 Key Competitors of the Company
6.5.4 Financials
6.5.5 Key Insights about the Financial Health of the Company
6.5.6 Analyst Perspective
6.6 QIAGEN
6.6.1 Company Overview
6.6.2 Role of QIAGEN in the Nucleic Acid Sample Preparation Market
6.6.3 Key Customers of the Company
6.6.4 Key Competitors of the Company
6.6.5 Business Strategies
6.6.6 Financials
6.6.7 Key Insights about the Financial Health of the Company
6.6.8 Analyst Perspective
6.7 Tecan Trading AG
6.7.1 Company Overview
6.7.2 Role of Tecan Trading AG in the Nucleic Acid Sample Preparation Market
6.7.3 Key Customers of the Company
6.7.4 Key Competitors of the Company
6.7.5 Financials
6.7.6 Key Insights about the Financial Health of the Company
6.7.7 Analyst Perspective
List of Figures
Figure 1: Nucleic Acid Sample Preparation Market, $Million, 2021 and 2032
Figure 2: Nucleic Acid Sample Preparation Market Segmentation
Figure 3: Share of Nucleic Acid Sample Preparation Market (by Product), $Million, 2021-2032
Figure 4: Share of Nucleic Acid Sample Preparation Market (by Workflow), $Million, 2021-2032
Figure 5: Share of Nucleic Acid Sample Preparation Market (by Technology), $Million, 2021-2032
Figure 6: Share of Nucleic Acid Sample Preparation Market (by Therapeutic Area), $Million, 2021-2032
Figure 7: Share of Nucleic Acid Sample Preparation Market (by Application), $Million, 2021 and 2032
Figure 8: Share of Nucleic Acid Sample Preparation Market (by End User), $Million, 2021 and 2032
Figure 9: Nucleic Acid Sample Preparation Market (by Region)
Figure 10: Nucleic Acid Sample Preparation Market Segmentation
Figure 11: Nucleic Acid Sample Preparation Market: Research Methodology
Figure 12: Primary Research Methodology
Figure 13: Bottom-Up Approach (Segment-Wise Analysis)
Figure 14: Top-Down Approach (Segment-Wise Analysis)
Figure 15: Nucleic Acid Sample Preparation Market, $Million, 2021-2032
Figure 16: Europe Nucleic Acid Sample Preparation Addressable Market, 2021-2032
Figure 17: Nucleic Acid Sample Preparation Market, Patent Analysis (by Year), January 2019-December 2022
Figure 18: Nucleic Acid Sample Preparation Market, Patent Analysis (by Country), January 2019-December 2022
Figure 19: Nucleic Acid Sample Preparation Market, Patent Analysis (by Region), January 2019-December 2022
Figure 20: Virus Testing Workflow
Figure 21: NGS Applications in Laboratories during COVID-19
Figure 22: Nucleic Acid Sample Preparation Market - Market Dynamics
Figure 23: Techniques for Nucleic Acid Extraction/Isolation
Figure 24: Benefits of Automated Nucleic Acid Sample Preparation
Figure 25: Share of Key Developments, January 2019-November 2022
Figure 26: Share of Synergistic Activities (by Company), January 2019-November 2022
Figure 27: Number of Business Expansion Activities (by Company), January 2019-November 2022
Figure 28: Number of Product Launches (by Company), January 2019-November 2022
Figure 29: Market Share Analysis of the Global Nucleic Acid Sample Preparation Market (by Company), 2021
Figure 30: Nucleic Acid Sample Preparation Market (by Region)
Figure 31: Nucleic Acid Sample Preparation Market (by Region), $Million, 2021-2032
Figure 32: Europe Nucleic Acid Sample Preparation Market, $Million, 2021-2032
Figure 33: Europe Nucleic Acid Sample Preparation Market (by Country), 2021 and 2032
Figure 34: Germany Nucleic Acid Sample Preparation Market, $Million, 2021-2032
Figure 35: France Nucleic Acid Sample Preparation Market, $Million, 2021-2032
Figure 36: U.K. Nucleic Acid Sample Preparation Market, $Million, 2021-2032
Figure 37: Italy Nucleic Acid Sample Preparation Market, $Million, 2021-2032
Figure 38: Spain Nucleic Acid Sample Preparation Market, $Million, 2021-2032
Figure 39: Rest-of-Europe Nucleic Acid Sample Preparation Market, $Million, 2021-2032
Figure 40: Total Number of Companies Profiled
Figure 41: Endress+Hauser Group Services AG (Analytik Jena GmbH): Product Portfolio
Figure 42: Endress+Hauser Group Services AG (Analytik Jena GmbH): Overall Financials, $Million, 2019-2021
Figure 43: Endress+Hauser Group Services AG (Analytik Jena GmbH): Revenue (by Segment), $Million, 2019-2021
Figure 44: Endress+Hauser Group Services AG (Analytik Jena GmbH): R&D Expenditure, $Million, 2019-2021
Figure 45: Eppendorf SE: Product Portfolio
Figure 46: Eppendorf SE: Overall Financials, $Million, 2019-2021
Figure 47: Eppendorf SE: Revenue (by Segment), $Million, 2019-2021
Figure 48: Eppendorf SE: Revenue (by Region), $Million, 2019-2021
Figure 49: Eppendorf SE: R&D Expenditure, $Million, 2019-2021
Figure 50: F. Hoffmann-La Roche Ltd: Product Portfolio
Figure 51: F. Hoffmann-La Roche Ltd: Overall Financials, $Million, 2019-2021
Figure 52: F. Hoffmann-La Roche Ltd: Revenue (by Segment), $Million, 2019-2021
Figure 53: F. Hoffmann-La Roche Ltd: Revenue (by Region), $Million, 2019-2021
Figure 54: F. Hoffmann-La Roche Ltd: R&D Expenditure, $Million, 2019-2021
Figure 55: Merck KGaA: Product Portfolio
Figure 56: Merck KGaA: Overall Financials, $Million, 2019-2021
Figure 57: Merck KGaA: Revenue (by Segment), $Million, 2019-2021
Figure 58: Merck KGaA: Revenue (by Region), $Million, 2019-2021
Figure 59: Merck KGaA: R&D Expenditure, $Million, 2019-2021
Figure 60: QIAGEN: Product Portfolio
Figure 61: QIAGEN: Overall Financials, 2019-2021
Figure 62: QIAGEN: Revenue (by Segment), 2019-2021
Figure 63: QIAGEN: Revenue (by Region), 2019-2021
Figure 64: QIAGEN: R&D Expenditure, 2019-2021
Figure 65: Tecan Trading AG: Product Portfolio
Figure 66: Tecan Trading AG: Overall Financials, 2019-2021
Figure 67: Tecan Trading AG: Revenue (by Segment), 2019-2021
Figure 68: Tecan Trading AG: Revenue (by Region), 2019-2021
Figure 69: Tecan Trading AG: R&D Expenditure, 2019-2021
List of Tables
Table 1: Impact Analysis of Market Drivers, Restraints, and Opportunities on the Nucleic Acid Sample Preparation Market
Table 2: Industry Participants’ Landscape in the Nucleic Acid Sample Preparation Market
Table 3: Cost of Automated Workstations